China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $21.7M
Liabilities Breakdown FY2025
Total Liabilities: $6.2M
Asset Breakdown
Total Assets: $21.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $18.1M | 83.7% |
| Accounts Receivable | $1.3M | 6.0% |
| Inventory | $828.1K | 3.8% |
| Property, Plant & Equipment | $178.6K | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $11.8K | 0.1% |
| Other Assets | $1.2M | 5.6% |
Liabilities Breakdown
Total Liabilities: $6.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 18.6% |
| Long-Term Debt | $96.3K | 1.5% |
| Other Liabilities | $5.0M | 79.8% |